FindTrial
Sign In

Long-term follow-up after tricuspid biological valve replacement

Long-term follow-up after tricuspid biological valve replacement

Status
Active, not recruiting
Phases
Unknown
Study type
Observational
Source
ChiCTR
Registry ID
ChiCTR2400094826
Enrollment
Unknown
Registered
2024-12-27
Start date
2024-12-30
Completion date
Unknown
Last updated
2025-01-06

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Tricuspid valve regurgitation or stenosis

Interventions

Biological valve replacement group:Tricuspid biological valve replacement

Sponsors

West China Hospital of Sichuan University
Lead Sponsor

Eligibility

Sex/Gender
All
Age
18 Years to No maximum

Inclusion criteria

Inclusion criteria: 1. Age 18 years or older, 2. Patients undergoing elective cardiac tricuspid biological valve replacement, 3. Patients with no previous history of thoracic surgery.

Exclusion criteria

Exclusion criteria: 1. Patients with severe peripheral vascular disease or mutation, 2. Patients with malignant tumors, 3. Patients who died during perioperative period, 4. Emergency surgery patients.

Design outcomes

Primary

MeasureTime frame
Overall survival rate;—

Countries

China

Contacts

Public ContactZhong Wu

West China Hospital of Sichuan University

wuzhong71@scu.edu.cn+86 189 8060 6046

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026